Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK562679PMID: 33017116
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 50-21-5; 77-92-9; 868-14-4
SID: 403031105; 403029880; 403033303
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of vaginal lactic acid, citric acid, and potassium bitartrate as a contraceptive. The ingredients are normal components of maternal blood and absorption from the vagina should be minimal. No special precautions are required during breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Lactic Acid, Citric Acid, and Potassium Bitartrate
CAS Registry Number
50-21-5; 77-92-9; 868-14-4
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- Prescription of Controlled Substances: Benefits and Risks.[StatPearls. 2026]Prescription of Controlled Substances: Benefits and Risks.Preuss CV, Kalava A, King KC. StatPearls. 2026 Jan
- Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.[Cochrane Database Syst Rev. 2023]Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.Cohen MA, Edelman A, Paynter R, Henderson JT. Cochrane Database Syst Rev. 2023 Jan 9; 1(1):CD014908. Epub 2023 Jan 9.
- Review Iodine.[Drugs and Lactation Database (...]Review Iodine.. Drugs and Lactation Database (LactMed®). 2006
- Review Lactic acid, citric acid, and potassium bitartrate non-hormonal prescription vaginal pH modulator (VPM) gel for the prevention of pregnancy.[Expert Rev Clin Pharmacol. 2022]Review Lactic acid, citric acid, and potassium bitartrate non-hormonal prescription vaginal pH modulator (VPM) gel for the prevention of pregnancy.Su S, Vincent KL. Expert Rev Clin Pharmacol. 2022 Jun; 15(6):659-670. Epub 2022 Jul 21.
- Tranexamic acid for preventing postpartum haemorrhage after caesarean section.[Cochrane Database Syst Rev. 2024]Tranexamic acid for preventing postpartum haemorrhage after caesarean section.Rohwer C, Rohwer A, Cluver C, Ker K, Hofmeyr GJ. Cochrane Database Syst Rev. 2024 Nov 13; 11(11):CD016278. Epub 2024 Nov 13.
- Lactic Acid, Citric Acid, and Potassium Bitartrate - Drugs and Lactation Databas...Lactic Acid, Citric Acid, and Potassium Bitartrate - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...